James Gowans - 16 Oct 2025 Form 4 Insider Report for Trilogy Metals Inc. (TMQ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Oct 2025, 19:23:11 UTC
Prior SEC filing
03 Sep 2025
Next SEC filing
02 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elaine Sanders as attorney-in-fact for James Gowans

Key filing fact

James Gowans filed Form 4 for Trilogy Metals Inc. (TMQ) on 17 Oct 2025.

Key facts

  • This page summarizes James Gowans's Form 4 filing for Trilogy Metals Inc. (TMQ).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Oct 2025, 19:23.

Change

  • Previous filing in this sequence was filed on 03 Sep 2025.
  • Current net transaction value: -$571,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001777289 Primary reporting owner

Gowans James

Relationship
Director
Address
C/O TRILOGY METALS INC., SUITE 901, 510 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, CANADA
Signature
/s/ Elaine Sanders as attorney-in-fact for James Gowans
Signature date
17 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMQ transaction

Common Shares

Options Exercise

Transaction value
$179,000
Shares
+100,000
Change %
+43%
Price
$1.79
Shares after
334,046
Date
16 Oct 2025
Ownership
Direct
Footnotes
F1
TMQ transaction

Common Shares

Sale

Transaction value
$750,000
Shares
-100,000
Change %
-30%
Price
$7.50*
Shares after
234,046
Date
16 Oct 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TMQ transaction Derivative

Director Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-100,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
16 Oct 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
100,000
Exercise price
$1.79
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Converted from Canadian exercise price of C$2.52 using an exchange rate of C$1.4048 = US$1.00.

Footnote F2

Converted from Canadian sale price of C$10.53821 using an exchange rate of C$1.4048 = US$1.00.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .